170 related articles for article (PubMed ID: 10624853)
1. Accelerated hyperfractionated radiotherapy in 149 patients with glioblastoma multiforme.
Lutterbach J; Weigel P; Guttenberger R; Hinkelbein W
Radiother Oncol; 1999 Oct; 53(1):49-52. PubMed ID: 10624853
[TBL] [Abstract][Full Text] [Related]
2. Continuous hyperfractionated accelerated radiotherapy in the treatment of high-grade astrocytomas.
Beşe NS; Uzel O; Turkan S; Okkan S
Radiother Oncol; 1998 May; 47(2):197-200. PubMed ID: 9683369
[TBL] [Abstract][Full Text] [Related]
3. Prognostic factors in glioblastoma multiforme. 10 years experience of a single institution.
Hulshof MC; Koot RW; Schimmel EC; Dekker F; Bosch DA; González González D
Strahlenther Onkol; 2001 Jun; 177(6):283-90. PubMed ID: 11446316
[TBL] [Abstract][Full Text] [Related]
4. Accelerated hyperfractionated radiotherapy for malignant gliomas.
Buatti JM; Marcus RB; Mendenhall WM; Friedman WA; Bova FJ
Int J Radiat Oncol Biol Phys; 1996 Mar; 34(4):785-92. PubMed ID: 8598354
[TBL] [Abstract][Full Text] [Related]
5. Phase III trial of accelerated hyperfractionation with or without difluromethylornithine (DFMO) versus standard fractionated radiotherapy with or without DFMO for newly diagnosed patients with glioblastoma multiforme.
Prados MD; Wara WM; Sneed PK; McDermott M; Chang SM; Rabbitt J; Page M; Malec M; Davis RL; Gutin PH; Lamborn K; Wilson CB; Phillips TL; Larson DA
Int J Radiat Oncol Biol Phys; 2001 Jan; 49(1):71-7. PubMed ID: 11163499
[TBL] [Abstract][Full Text] [Related]
6. Postoperative radiotherapy of glioblastoma multiforme: analysis and critical assessment of different treatment strategies and predictive factors.
Piroth MD; Gagel B; Pinkawa M; Stanzel S; Asadpour B; Eble MJ
Strahlenther Onkol; 2007 Dec; 183(12):695-702. PubMed ID: 18040615
[TBL] [Abstract][Full Text] [Related]
7. Hyperfractionated and accelerated-hyperfractionated radiotherapy for glioblastoma multiforme.
Nieder C; Nestle U; Ketter R; Kolles H; Gentner SJ; Steudel WI; Schnabel K
Radiat Oncol Investig; 1999; 7(1):36-41. PubMed ID: 10030622
[TBL] [Abstract][Full Text] [Related]
8. Radiotherapy of glioblastoma multiforme. Feasibility of increased fraction size and shortened overall treatment.
Lang O; Liebermeister E; Liesegang J; Sautter-Bihl ML
Strahlenther Onkol; 1998 Dec; 174(12):629-32. PubMed ID: 9879350
[TBL] [Abstract][Full Text] [Related]
9. High dose hyperfractionated radiotherapy for adults with glioblastomas.
Koukourakis M; Scarlatos J; Yiannakakis D; Kordiolis N; Zambatis H; Sotiropoulou A
Med Dosim; 1993; 18(3):99-105. PubMed ID: 8280367
[TBL] [Abstract][Full Text] [Related]
10. Multivariate analysis of prognostic factors in patients with glioblastoma.
Lutterbach J; Sauerbrei W; Guttenberger R
Strahlenther Onkol; 2003 Jan; 179(1):8-15. PubMed ID: 12540979
[TBL] [Abstract][Full Text] [Related]
11. Gamma knife stereotactic radiosurgery for patients with glioblastoma multiforme.
Nwokedi EC; DiBiase SJ; Jabbour S; Herman J; Amin P; Chin LS
Neurosurgery; 2002 Jan; 50(1):41-6; discussion 46-7. PubMed ID: 11844233
[TBL] [Abstract][Full Text] [Related]
12. Survival following CyberKnife radiosurgery and hypofractionated radiotherapy for newly diagnosed glioblastoma multiforme.
Lipani JD; Jackson PS; Soltys SG; Sato K; Adler JR
Technol Cancer Res Treat; 2008 Jun; 7(3):249-55. PubMed ID: 18473497
[TBL] [Abstract][Full Text] [Related]
13. Phase I trial of gross total resection, permanent iodine-125 brachytherapy, and hyperfractionated radiotherapy for newly diagnosed glioblastoma multiforme.
Chen AM; Chang S; Pouliot J; Sneed PK; Prados MD; Lamborn KR; Malec MK; McDermott MW; Berger MS; Larson DA
Int J Radiat Oncol Biol Phys; 2007 Nov; 69(3):825-30. PubMed ID: 17512132
[TBL] [Abstract][Full Text] [Related]
14. Prognostic impact of hemoglobin level prior to radiotherapy on survival in patients with glioblastoma.
Odrazka K; Petera J; Kohlova T; Dolezel M; Vaculikova M; Zouhar M; Malek V; Hobza V; Latr I; Nemecek S; Sercl M; Ryska P; Blaha M; Cermakova E
Strahlenther Onkol; 2003 Sep; 179(9):615-9. PubMed ID: 14628127
[TBL] [Abstract][Full Text] [Related]
15. National Cancer Institute (phase II) study of high-grade glioma treated with accelerated hyperfractionated radiation and iododeoxyuridine: results in anaplastic astrocytoma.
Sullivan FJ; Herscher LL; Cook JA; Smith J; Steinberg SM; Epstein AH; Oldfield EH; Goffman TE; Kinsella TJ; Mitchell JB
Int J Radiat Oncol Biol Phys; 1994 Oct; 30(3):583-90. PubMed ID: 7928489
[TBL] [Abstract][Full Text] [Related]
16. Phase II, two-arm RTOG trial (94-11) of bischloroethyl-nitrosourea plus accelerated hyperfractionated radiotherapy (64.0 or 70.4 Gy) based on tumor volume (> 20 or < or = 20 cm(2), respectively) in the treatment of newly-diagnosed radiosurgery-ineligible glioblastoma multiforme patients.
Coughlin C; Scott C; Langer C; Coia L; Curran W; Rubin P
Int J Radiat Oncol Biol Phys; 2000 Dec; 48(5):1351-8. PubMed ID: 11121633
[TBL] [Abstract][Full Text] [Related]
17. The use of hypofractionated intensity-modulated irradiation in the treatment of glioblastoma multiforme: preliminary results of a prospective trial.
Sultanem K; Patrocinio H; Lambert C; Corns R; Leblanc R; Parker W; Shenouda G; Souhami L
Int J Radiat Oncol Biol Phys; 2004 Jan; 58(1):247-52. PubMed ID: 14697445
[TBL] [Abstract][Full Text] [Related]
18. [Combined surgery and radiotherapy of glioblastoma multiforme--report of 73 cases].
Lei YH
Zhonghua Zhong Liu Za Zhi; 1990 Nov; 12(6):469-71. PubMed ID: 1963841
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of high dose radiotherapy in post-operative treatment of glioblastoma multiform--a single institution report.
Pashaki AS; Hamed EA; Mohamadian K; Abassi M; Safaei AM; Torkaman T
Asian Pac J Cancer Prev; 2014; 15(6):2793-6. PubMed ID: 24761902
[TBL] [Abstract][Full Text] [Related]
20. Accelerated hyperfractionated radiotherapy in supratentorial malignant astrocytomas.
Genc M; Zorlu AF; Atahan IL
Radiother Oncol; 2000 Aug; 56(2):233-8. PubMed ID: 10927143
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
